Data / Form D filings / SEQUELLA INC.
SEQUELLA INC.: Form D filings
SEQUELLA INC., a pharmaceuticals company in Rockville, MD, filed 12 Form D notices with the SEC between 2009 and 2017. The latest, on October 10, 2017, reports $630,589 sold of a $3.6 million offering to 6 investors.
Find out what SEQUELLA INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9610 MEDICAL CENTER DR, SUITE 200, Rockville, MD, 20850
- Phone
- (301) 762-7776
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1065544
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 10, 2017 | New notice | $3,624,753 | $630,589 | $2,994,164 | 6 | Sep 7, 2017 | sec.gov |
| Sep 22, 2016 | New notice | $940,942 | $940,942 | $0 | 9 | Aug 3, 2016 | sec.gov |
| Sep 22, 2016 | New notice | $3,006,250 | $1,724,250 | $1,282,000 | 9 | Aug 3, 2016 | sec.gov |
| Oct 10, 2014 | New notice | $3,100,000 | $3,100,000 | $0 | 36 | Sep 26, 2014 | sec.gov |
| Oct 1, 2013 | New notice | $2,400,000 | $555,000 | $1,845,000 | 3 | Aug 28, 2013 | sec.gov |
| Sep 4, 2012 | New notice | $3,000,000 | $100,000 | $2,900,000 | 2 | Aug 22, 2012 | sec.gov |
| Nov 4, 2011 | New notice | $3,000,000 | $50,000 | $2,950,000 | 2 | Oct 19, 2011 | sec.gov |
| Aug 10, 2011 | New notice | $4,000,000 | $550,000 | $3,450,000 | 5 | Aug 1, 2011 | sec.gov |
| Jun 2, 2011 | New notice | $1,500,000 | $1,000,000 | $500,000 | 1 | May 13, 2011 | sec.gov |
| Feb 22, 2010 | New notice | $6,000,000 | $2,000,000 | $4,000,000 | 1 | Feb 16, 2010 | sec.gov |
| Aug 20, 2009 | New notice | $1,800,000 | $1,500,000 | $300,000 | 4 | Aug 6, 2009 | sec.gov |
| Jul 9, 2009 | New notice | $720,097 | $720,097 | $0 | 1 | Jun 15, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MARK I. RAMPY | Executive Officer | |
| LAWRENCE I. MILLER | Executive Officer | |
| RONALD I. MELTZER | Director | |
| CAROL A. NACY | Executive Officer, Director | |
| DAVID I. MCNEELEY | Executive Officer | |
| LEO A. EINCK | Executive Officer, Director | |
| BRADLEY I. ROTTER | Director | |
| JOHN I. FRIEDMAN | Director | |
| PAIGE I. MACDONALD | Director |
Every Form D from the week of Oct 9, 2017 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SEQUELLA INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.